about
The effectiveness of electronic screening and brief intervention for reducing levels of alcohol consumption: a systematic review and meta-analysisMephedrone, new kid for the chop?Buprenorphine mortality, seizures and prescription data in the UK, 1980-2002.Promoting innovation and excellence to face the rapid diffusion of novel psychoactive substances in the EU: the outcomes of the ReDNet project.Linked randomised controlled trials of face-to-face and electronic brief intervention methods to prevent alcohol related harm in young people aged 14-17 years presenting to Emergency Departments (SIPS junior).User Preferences for Content, Features, and Style for an App to Reduce Harmful Drinking in Young Adults: Analysis of User Feedback in App Stores and Focus Group Interviews.Screening and brief interventions for hazardous alcohol use in accident and emergency departments: a randomised controlled trial protocol.Screening and brief interventions for hazardous and harmful alcohol use in primary care: a cluster randomised controlled trial protocol.The effectiveness of alcohol screening and brief intervention in emergency departments: a multicentre pragmatic cluster randomized controlled trialMephedrone (4-methylmethcathinone; 'meow meow'): chemical, pharmacological and clinical issues.Designer drugs on the internet: a phenomenon out-of-control? the emergence of hallucinogenic drug Bromo-Dragonfly.Phenomenon of new drugs on the Internet: the case of ketamine derivative methoxetamine.Pragmatic randomised controlled trial to evaluate the effectiveness and cost effectiveness of a multi-component intervention to reduce substance use and risk-taking behaviour in adolescents involved in the criminal justice system: A trial protocol (New trends in the cyber and street market of recreational drugs? The case of 2C-T-7 ('Blue Mystic').Drugs on the web; the Psychonaut 2002 EU project.Implementing training and support, financial reimbursement, and referral to an internet-based brief advice program to improve the early identification of hazardous and harmful alcohol consumption in primary care (ODHIN): study protocol for a clusterBrief intervention to prevent hazardous drinking in young people aged 14-15 in a high school setting (SIPS JR-HIGH): study protocol for a randomized controlled trial.Impact of primary healthcare providers' initial role security and therapeutic commitment on implementing brief interventions in managing risky alcohol consumption: a cluster randomised factorial trial.Medical professionals' perspectives on prescribed and over-the-counter medicines containing codeine: a cross-sectional study.How Resistant to Tampering are Codeine Containing Analgesics on the Market? Assessing the Potential for Opioid Extraction.Multicentre individual randomised controlled trial of screening and brief alcohol intervention to prevent risky drinking in young people aged 14-15 in a high school setting (SIPS JR-HIGH): study protocol.Alcohol screening and brief intervention for adolescents: the how, what and where of reducing alcohol consumption and related harm among young people.Assertive Community Treatment For People With Alcohol Dependence: A Pilot Randomized Controlled Trial.Identifying the gap between need and intervention for alcohol use disorders in Europe.A market on both "sides" of the law: The use of the hidden web for the sale of new psychoactive substances.Codeine use, dependence and help-seeking behaviour in the UK and Ireland: an online cross-sectional survey.Novel psychoactive substances: An investigation of temporal trends in social media and electronic health records.Identifying emerging trends in recreational drug use; outcomes from the Psychonaut Web Mapping Project.Substitutional potential of mephedrone: an analysis of the subjective effects.Codeine misuse and dependence in South Africa: Perspectives of addiction treatment providers.Usability Testing of the BRANCH Smartphone App Designed to Reduce Harmful Drinking in Young Adults.Do we have sufficient information to optimally inform regulatory or other policy decisions about medications containing codeine?Tampering of opioid analgesics: a serious challenge for public health?Ecstasy (MDMA, MDA, MDEA, MBDB) consumption, seizures, related offences, prices, dosage levels and deaths in the UK (1994-2003).[Analysis of online reports on the potential misuse of benzidamine].Low identification of alcohol use disorders in general practice in England.Searching the Internet for drug-related web sites: analysis of online available information on ecstasy (MDMA).Delivery of Brief Interventions for Heavy Drinking in Primary Care: Outcomes of the ODHIN 5-Country Cluster Randomized Trial.Improving screening and brief intervention activities in primary health care: Secondary analysis of professional accuracy based on the AUDIT-C.A National Survey of Assertive Outreach Treatment Services for People Who Frequently Attend Hospital due to Alcohol-Related Reasons in England.
P50
Q27007113-C3699F2A-FDB4-4510-B1E4-F09EB56BCCA0Q30392896-8775D4FA-EBC4-4C28-AAE0-348F00304CBCQ30992115-80B47DFC-5344-4EFC-A141-A2EE12161F79Q33439861-8BDDB33C-2AFB-4775-86B4-19DEEC3894CFQ33443309-167BDDE7-A5E5-4385-A465-B700059FB807Q33448881-FBF477A3-5B85-44AC-B226-55D3192A3606Q33477990-DF173491-9870-4550-B0DF-F1B0B72AA462Q33491839-1AB1C1F8-D09D-4EF7-8499-0B697D6A29E1Q33806511-E1FAB285-5F59-49A9-ABA8-3FDA00F9F52CQ34149434-6ACDF501-C0B3-4238-8361-56DFECF523FAQ34185831-363D6522-31DF-4DCF-8C2B-D5EF05688865Q34258539-A7B44D52-FF70-4F11-BCD0-CA1665792AEBQ36305079-DA88681C-CD0A-4617-9A1B-BC386ABFE0A1Q36307104-3E224BDB-68A8-4975-AEA9-7C9ABC7AF2F9Q36386840-19D21D6A-FC9C-417A-8427-FF7207781733Q36588467-01AE21BE-CDE7-4CEA-9C61-8DF02994A57DQ37000910-A1442E5B-7E70-487F-A38A-D71C64C4A472Q37099785-F0798A8D-D4B6-4958-9506-854445CAD87AQ37101162-59A9FB52-C1F2-4586-AB72-7A0C458E87D5Q37459006-49A34965-86EA-4038-B98D-C12196AC1728Q37576732-3FB7B945-0A46-4FD4-A2EC-126A2882DE85Q37599700-7638B497-F0E6-4CDA-B640-0E9C2CBB9415Q37735585-DFE83627-82BA-4579-8088-D1A2C5864051Q37842767-E2FA3F58-0BC0-4407-ADFF-8BB11AA560B7Q38724279-B0FB692F-0CC2-496C-948F-C53E1912134EQ38853123-41DD5875-A5EB-4CEC-B7D9-4985FDB0FE0DQ39407266-338EECA7-0218-4614-AA55-9745353189FFQ39578354-7D1EB6AF-0500-4914-90DD-BAFC39FA3230Q40126464-D67C1813-428D-4A08-B3B0-4503CE288DC1Q40206566-50A6EF48-7034-43B2-A693-DB7818EF609FQ40494061-B91C44FC-CB72-4282-96F2-B5B6443E747EQ44153501-6F070C99-BFB5-4262-B5AB-9046211D0301Q44337858-C9A3BB3F-7916-454A-9817-B9DA0DC10047Q44915720-C33FB769-FC36-412D-8D87-324FF2D79DB0Q45902923-89CE9E18-378A-48B0-A237-FB5CC929627CQ46644606-C3CE73F1-44F4-4FD7-8D50-04C3AE135CA4Q46866966-514DD924-A42D-48E1-B7AA-157664B12615Q47149138-4C58AD96-8F0D-44B2-9600-7F78BFCEB68EQ47568767-8E42C81D-B5E7-461D-8B2F-E83A2CD9962CQ47569909-7CB15FD3-AF6D-4345-BA28-9B9B1BFB9CEE
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Paolo Deluca
@ast
Paolo Deluca
@en
Paolo Deluca
@es
Paolo Deluca
@nl
Paolo Deluca
@sl
type
label
Paolo Deluca
@ast
Paolo Deluca
@en
Paolo Deluca
@es
Paolo Deluca
@nl
Paolo Deluca
@sl
prefLabel
Paolo Deluca
@ast
Paolo Deluca
@en
Paolo Deluca
@es
Paolo Deluca
@nl
Paolo Deluca
@sl
P106
P1153
8676467300
P21
P31
P496
0000-0002-9511-7230